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Abstract
Background: The effective orifice area (EOA) estimated by transthoracic Doppler echocardiography (TTE) via the
continuity equation is commonly used to determine the severity of aortic stenosis (AS). However, there are often
discrepancies between TTE-derived EOA and invasive indices of stenosis, thus raising uncertainty about actual
definite severity. Cardiovascular magnetic resonance (CMR) has emerged as an alternative method for non-invasive
estimation of valve EOA. The objective of this study was to assess the concordance between TTE and CMR for the
estimation of valve EOA.
Methods and results: 31 patients with mild to severe AS (EOA range: 0.72 to 1.73 cm2) and seven (7) healthy
control subjects with normal transvalvular flow rate underwent TTE and velocity-encoded CMR. Valve EOA was
calculated by the continuity equation. CMR revealed that the left ventricular outflow tract (LVOT) cross-section is
typically oval and not circular. As a consequence, TTE underestimated the LVOT cross-sectional area (ALVOT, 3.84 ±
0.80 cm2) compared to CMR (4.78 ± 1.05 cm2). On the other hand, TTE overestimated the LVOT velocity-time
integral (VTILVOT: 21 ± 4 vs. 15 ± 4 cm). Good concordance was observed between TTE and CMR for estimation of
aortic jet VTI (61 ± 22 vs. 57 ± 20 cm). Overall, there was a good correlation and concordance between TTE-
derived and CMR-derived EOAs (1.53 ± 0.67 vs. 1.59 ± 0.73 cm2, r = 0.92, bias = 0.06 ± 0.29 cm2). The intra- and
inter- observer variability of TTE-derived EOA was 5 ± 5% and 9 ± 5%, respectively, compared to 2 ± 1% and 7 ±
5% for CMR-derived EOA.
Conclusion: Underestimation of ALVOT by TTE is compensated by overestimation of VTILVOT, thereby resulting in a
good concordance between TTE and CMR for estimation of aortic valve EOA. CMR was associated with less intra-
and inter- observer measurement variability compared to TTE. CMR provides a non-invasive and reliable alternative
to Doppler-echocardiography for the quantification of AS severity.
Background
Accurate assessment of valve stenosis severity is crucial
for optimal management of patients with aortic stenosis
(AS). The valve effective orifice area (EOA) is one of the
most frequently used index to quantify stenosis severity
and current ACC/AHA/ESC guidelines propose an EOA
< 1.0 cm2 as the criteria to be utilized to identify severe
AS [1,2]. Given its non-invasive, radiation-free, low-cost,
and versatility nature, transthoracic Doppler-echocardio-
graphy (TTE) is currently the method of choice to mea-
sure the valve EOA and grade AS severity. However,
TTE has several limitations including: i) inability to
obtain reliable measurements of EOA due to inadequate
acoustic window and poor image quality in some
patients; ii) potential for underestimation of flow velo-
city due to mis-alignment of Doppler beam with flow
direction; iii) risk of underestimation of LV outflow
(LVOT) diameter due to inadequate quality and/or posi-
tioning of image plane; iv) measurement variability
related to manual tracing of flow velocity contours, etc
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[1]. These limitations may significantly alter the perfor-
mance of TTE to accurately quantify AS severity.
Furthermore, the cardiologist if often confronted to dis-
cordant results among the different stenotic indices (i.e.
EOA, transvalvular gradient, peak velocity, dimension-
less velocity index) measured by Doppler-echocardiogra-
phy or between the Doppler-echocardiographic
evaluation of stenosis severity and the patient’s clinical
status [3]. These discordances may raise some uncer-
tainty about the actual severity of the stenosis and thus
about the indication for aortic valve replacement if the
patient is symptomatic. When Doppler-echocardio-
graphic evaluation is inconclusive and/or discordant
with other clinical findings, catheterization may be used
to confirm valve EOA and gradients. However, left heart
catheterization is an invasive method that may cause
cerebral embolism [4]. Cardiovascular magnetic reso-
nance (CMR) has emerged as a non-invasive, radiation-
free alternative modality to corroborate AS severity
[5-10]. The majority of previous studies have, however,
focused on the evaluation of the valvular anatomic (geo-
metric) orifice area measured by planimetry on the
images obtained by CMR or computed tomography
[11-13]. From a physiologic standpoint, it is important
to emphasize that the transvalvular pressure gradient
and thus the LV workload are essentially determined by
the valve EOA, i.e. the cross-sectional area of the vena
contracta of the transvalvular flow jet, and not by the
valve anatomic orifice area [14,15]. And in this regard, it
should be noted that the anatomic and effective orifice
areas may differ markedly, depending on the magnitude
of the flow contraction downstream of the valve.
The objective of this study was to assess the concor-
dance between TTE and CMR for the estimation of
valve EOA with use of the continuity equation method.
Methods
Study Population
Seven (7) healthy control subjects and 31 patients with
mild to severe AS (0.72 cm2 ≤ EOA ≤ 1.73 cm2) were
included in this study. Exclusion criteria were: age < 21
years old, LV ejection fraction < 50%, atrial fibrillation,
moderate or severe mitral or aortic regurgitation, poor
TTE imaging quality and standard contra-indications to
magnetic resonance imaging. All patients provided written
informed consent. Initial AS severity classification at study
entry was based on TTE-derived EOA: normal (EOA > 2.0
cm2), mild (1.5 cm2 < EOA ≤ 2.0 cm2), moderate (1.0 cm2
< EOA ≤ 1.5 cm2) and severe (EOA ≤ 1.0 cm2).
Transthoracic Echocardiography
TTE studies were performed and analyzed by two experi-
enced echocardiographers. The TTE measurements were
performed according to the American Society of Echo-
cardiography guidelines [16] and included: LVOT dia-
meter, LVOT flow velocity by pulsed-wave Doppler,
aortic transvalvular jet velocity by continuous-wave Dop-
pler and valve EOA using continuity equation [1]:
EOATTE = SVLVOT/VTIAo = (VTILVOT × ALVOT)/VTIAo (1)
Where SVLVOT is the stroke volume measured in the
LVOT, ALVOT is the cross-sectional area of the LVOT
calculated assuming a circular shape: (LVOT diameter)2
× 0.785. and VTILVOT VTIAo are the velocity-time inte-
grals of the LVOT and transvalvular flow, respectively.
Cardiovascular Magnetic Resonance
CMR studies were performed 2 to 4 weeks after TTE
with patients in comparable hemodynamic state. Imaging
was performed with a 1.5 Tesla Philips Achieva scanner
operating release 2.6 level 3 and dedicated phased-array
cardiac coil during successive end-expiratory breath-
holds (Philips Healthcare, Best, The Netherlands). Cine
imaging of cardiac function was performed by steady-
state free precession technique at 30 phases per cardiac
cycle (by vectorcardiographic gating) in 8-14 parallel
short-axis and 2-chamber, 4-chamber, and 2 orthogonal
LVOT planes (8 mm thickness, 0 mm gap). Typical para-
meters included TR/TE of 3.4/1.2 ms, flip angle 40°, NEX
of 1, yielding in-plane spatial resolution of 1.6 × 2 mm.
In addition, through-plane phase-contrast (sQFlow
SENSE) imaging was performed in the LVOT at 12 mm
upstream from the aortic valve annulus (reference: 0
mm) and in the ascending aorta at +6 mm and +10 mm
downstream of the annulus (Figure 1). CMR imaging
parameters consisted of: TR/TE of 4.60-4.92/2.76-3.05
ms, flip angle 15°, 24 phases, pixel spacing 1.32-2.07 mm,
slice thickness 10 mm and acquisition matrix of 256 ×
208. Each phase-contrast velocity mapping acquisition
produced 2 cine images: one magnitude image and one
phase image. For each patient, peak aortic jet velocity
measured by TTE was used to define CMR encoding
velocity (CMR encoding velocity = (1.25 to 1.5) × peak
jet velocity) to optimally define resolution.
CMR images acquisitions and analyses were per-
formed by investigators blinded to clinical and TTE
results. A custom-made research application was devel-
oped using Matlab software (Mathworks, Natick, Ma) to
process and analyze velocity-encoded images [17]. Spa-
tial resolution of CMR images was artificially improved
by a factor of three using bicubic averaged interpolation
and the magnitude image stack was processed to filter
background noise. Regions of interest (ROIs) were
defined on each of the 24 phases of magnitude images
to include the lumen of the LVOT and of the aorta.
The following measurements were performed within
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each ROI: i) on magnitude images: anterior-posterior
(AP) diameter, left-right (LR) diameter, and cross-sec-
tional area of LVOT at the -12 mm position; the ratio
of AP/LR diameters was calculated to characterize the
shape of LVOT (the lower the ratio the more oval the
shape of LVOT) (Figure 2) and ii) on matched phase
images: velocity profiles at -12 mm, +6 and +10 mm
positions.
The peak and average flow velocities within the ROI
were used to determine the changes in instantaneous
peak (Vpeak, Figure 3A) and average (Vaverage, Figure 3B)
velocity in the LVOT at the -12 mm position during the
cardiac cycle. The velocity-time integral of Vaverage dur-
ing systole was calculated (Figure 3B) and compared to
the VTI measured by TTE in the LVOT. The instanta-
neous LVOT flow rate was calculated by multiplying the
instantaneous Vaverage by the LVOT cross-sectional area,
and the stroke volume (SVCMR) was calculated by using
Simpson’s rule to integrate flow during systole (Figure
3C).
The peak flow velocity within the ROI was used to
determine the instantaneous peak aortic velocity at the
6 and 10 mm positions (Figure 3D). The velocity-time
integral of peak velocity during systole was calculated
(VTIAo) and compared to the VTIAo measured by TTE.
Given that slightly higher velocities were obtained at 6
mm versus 10 mm, we used the 6 mm position for esti-
mation of VTIAo and EOA by CMR in this study.
The CMR-derived EOA (EOACMR) was then calcu-
lated with the following formula:
EOACMR = SVCMR/VTIAo (2)
Where SVCMR is the stroke volume using Simpson’s
rule to integrate systolic flow and VTIAo is the velocity-
time integral of the peak aortic flow velocity measured
at 6 mm downstream of the valve during systole.
Measurement variability
To evaluate the intra- and inter- observer variability
related to image analysis by CMR and TTE; the mea-
surements of EOA were repeated in a subset of 15 stu-
dies (11 AS patients and 4 control subjects) by two
blinded observers with the use of the same set of TTE
and CMR images. To further evaluate the intra- and
inter- observer- variability related to image acquisition
and analysis by TTE and CMR, 5 AS patients were
imaged twice within 4 weeks (including image acquisi-
tion and analysis).
Figure 1 Image planes used for CMR measurements. Panel A shows the flow velocity map was acquired at 3 image planes: -12 mm
upstream from aortic valve plane (used as the 0 mm reference) and at +6 and +10 mm downstream of the aortic valve plane. The cross-
sectional area of the LVOT is measured at the -12 mm position. Panel B shows the measurement of LVOT diameter at annulus location.
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Statistical analyses
Results are expressed as mean ± SD. CMR versus TTE
measurements were compared by 2-tailed paired Stu-
dent t-tests. Correlations and agreements between CMR
and TTE measurements were assessed by Pearson’s cor-
relations and Bland-Altman comparisons, respectively.
Statistical analysis was performed with SPSS 17 (SPSS,
Chicago, IL).
Results
Thirty-one patients with mild to severe AS (77% men,
age 67 ± 12 years) and seven healthy subjects (71% men,
age 34 ± 8 years) were studied by TTE and CMR. Valve
morphology was bicuspid in nine of the 31 AS patients
and indeterminate by TTE in 3 patients. Patient charac-
teristics are reported in Table 1.
LVOT cross-sectional area
LVOT cross-sectional area obtained by TTE was smaller
than that obtained by CMR (bias = -0.94 cm2, agree-
ment limits: -2.62 to + 0.74 cm2) (Table 2). This is, in
large part, due to the fact that TTE assumes a circular
shape of LVOT and uses the smaller (AP diameter) to
compute ALVOT, whereas CMR reveals that LVOT
shape is oval in the vast majority of patients (Figure 2).
The LR and AP LVOT diameters measured by CMR
were: 28 ± 3 mm and 24 ± 3 mm, respectively, whereas
the LVOT diameter measured by TTE was: 22 ± 1 mm.
The ratio of AP to LR diameters measured by CMR was
0.87 ± 0.08 (median: 0.86; range: 0.78 - 0.94) and overall
74% of patients had a ratio < 0.9, thus confirming that
most patients have an oval-shape of LVOT. There was
no difference in AP to LR diameters ratio between
bicuspid vs. tricuspid valves (0.83 ± 0.07 vs. 0.88 ± 0.08,
p = NS)
LVOT flow velocities and stroke volume
VTILVOT measured by TTE was greater than that mea-
sured by CMR (bias = 14 cm and agreement limits: +1
to +26 cm) (Table 2). This may be due to the fact
Doppler-echocardiography measures the flow velocity
at the center of the LVOT, assuming an homogeneous
and flat velocity profile, whereas CMR reveals that the
flow velocity profile is skewed with greater velocities
along the anterior and right aspects of the LVOT
(Figure 4).
Aortic valve EOA
Overall, there was a good correlation and concordance
between EOATTE and EOACMR (1.53 ± 0.67 cm
2 vs. 1.59
± 0.73 cm2, r = 0.92, bias = +0.06 cm2, agreement limits:
-0.50 to +0.62 cm2; Figure 5). Nonetheless, 12 (39%)
patients had a change in AS severity class when using
the EOACMR rather than the EOATTE (Figure 6). Four
(13%) patients were re-classified in a more severe class
and 8 (26%) in a less severe class. Two (6%) patients
with severe AS on the basis of EOATTE were re-classi-
fied as moderate by EOACMR and three (9%) patients
Figure 2 Left ventricular outflow tract dimensions and cross-section area measurements by CMR. Left ventricular outflow tract (LVOT)
cross-sectional (ALVOT; red solid line), anterior-posterior (AP) diameter (blue line), right-left (RL) diameter (blue line), and AP/RL diameter ratio for
two different patients. The dashed red line represents the cross-sectional area of LVOT estimated on the basis of the AP diameter and assuming
a circular LVOT shape. This estimation yielded values of LVOT cross-sectional area of 6.15 and 3.46 cm2 for these 2 patients compared to the
actual area of 6.23 and 5.35 cm2, respectively.
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Figure 3 Flow velocity measurements in the left ventricular outflow tract by CMR. Panel A shows the change in peak left ventricular
outflow tract (LVOT) velocity at -12 mm position during the cardiac cycle. Panel B shows the change in the instantaneous average velocity
obtained over the region of interest. The velocity-time integral (VTI) is the area under the curve. Panel C shows the change in instantaneous flow
(Q) calculated as follows: Q (t) = average velocity (t) × ALVOT, where ALVOT is the cross-sectional area of the LVOT. The stroke volume (SV) is the
flow-time integral during systole. Panel D shows the change in peak aortic velocity at +6 mm position during the cardiac cycle, the velocity-time
integral (VTI) is the area under the curve.
Table 1 Patient Characteristics
Age (years) 62 ± 17
Male gender n (%) 29 (76)
Heart rate (bpm) 65 ± 12
Weight (Kg) 76 ± 13
Height (cm) 169 ± 10
Body surface area (m2) 1.88 ± 0.19
Body mass index (Kg/m2) 26 ± 3
Valve morphology
Tricuspid n (%) 26 (68)
Bicuspid n (%) 9 (24)
Indeterminate n (%) 3 (8)
The table shows the mean ± SD or number of patients and percentage.
Table 2 Comparison of Transthoracic Doppler-
echocardiography (TTE) and Cardiovascular Magnetic
Resonance (CMR) data
TTE CMR
Mean ± SD Mean ± SD p-value
Heart rate (bpm) 65 ± 12 66 ± 11 0.40
LVOT area (cm2) 3.84 ± 0.8 4.78 ± 1.05 < 0.001
AP/RL diameter ratio 0.87 ± 0.08 -
LVOT VTI (cm) 21 ± 4 15 ± 4 < 0.001
SV (mL) 80 ± 13 80 ± 18 0.68
Ao VTI (cm) 61 ± 22 57 ± 20 0.02
EOA (cm2) 1.53 ± 0.67 1.59 ± 0.73 0.17
LVOT: Left ventricular outflow tract; AP: Anterior-Posterior diameter; RL: Right-
Left diameter; LVOT VTI: flow velocity time-integral in LVOT; SV: Stroke volume;
Ao VTI: peak aortic velocity-time integral; EOA: valve effective orifice area.
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with moderate AS on the basis of EOATTE were classi-
fied as severe by EOACMR.
Measurement variability
In the subset of 15 subjects (11 AS patients and 4 con-
trol subjects) in whom the analyses of EOA were
repeated on the same set of images, the intra- and inter-
observer variability of EOATTE was 5 ± 5% and 9 ± 5%,
respectively, compared to 2 ± 1% and 7 ± 5% for CMR.
Figure 4 Flow velocity profile obtained by CMR in the LV
outflow tract (LVOT). The figure shows the flow velocity profile
within the LVOT in a patient with AS. Panels A and B show the 2D
and 3D flow velocity profile.
Figure 5 Comparison of valve effective orifice area (EOA)
measured by TTE versus by CMR. Panel A shows the Pearson
correlation plot. The solid line is the regression line and the dashed
line is the identity line. Panel B shows the Bland-Altman plot. The
solid line is the mean bias and dashed lines are ± 1.96 standard-
deviations lines.
Figure 6 Grading of aortic stenosis severity with the use of
TTE- versus CMR-derived effective orifice areas (EOA).
Garcia et al. Journal of Cardiovascular Magnetic Resonance 2011, 13:25
http://www.jcmr-online.com/content/13/1/25
Page 6 of 9
In the subset of 5 patients in whom both the acquisition
and analysis of images were repeated, the intra- and
inter- observer variability of EOATTE was 10 ± 8% and
12 ± 5%, respectively, compared to 8 ± 8% and 9 ± 8%,
for EOACMR.
Discussion
Doppler-echocardiography is the method used to assess
AS severity and guide therapeutic management in cur-
rent practice. The valve EOA is one of the most fre-
quently used Doppler-echocardiographic index to
quantify stenosis severity. However, the measurement of
valve EOA may not be feasible in a significant propor-
tion of patients due to poor acoustic window and/or
subvalvular flow acceleration. Moreover, given that the
calculation of EOA requires the inclusion of 3 measures
(LVOT diameter, LVOT VTI, and aortic jet VTI) in the
continuity equation, this method may yield to relatively
large measurement errors. Finally, there are often dis-
cordances between EOA and other Doppler-echocardio-
graphic indices of stenosis severity, such as peak aortic
jet velocity and transvalvular gradients. These discor-
dances are particularly frequent in presence of low flow
state conditions, where the gradients may be low despite
the presence of a severe stenosis [18,19]. Discordant or
inconclusive Doppler-echocardiographic findings may
raise some uncertainty about the actual severity of the
stenosis and therefore about the therapeutic manage-
ment of the patient. There is thus an important need
for additional non-invasive and accurate methods to
corroborate stenosis severity in patients for whom Dop-
pler-echocardiography does not provide a definitive con-
clusion with regard to AS severity.
Multidetector computed tomography is a powerful
imaging modality to measure dimensions, surfaces and
volumes of cardiac chambers. However, this method
does not allow measurement of flow velocity and
thereby does not permit the determination of valve
EOA. CMR is a non-invasive, radiation-free imaging
modality that allows quantification of flow velocity in
the LVOT and aorta. Moreover CMR has superior tem-
poral resolution compared to computed tomography.
The main finding of this study is that there is a good
agreement between CMR and Doppler-echocardiogra-
phy for the estimation of valve EOA. This study also
confirms the results of previous studies that reported
that Doppler-echocardiography underestimates the
LVOT cross-sectional area compared to computed
tomography imaging [20-26]. This overestimation is
essentially related to the fact that Doppler-echocardio-
graphy assumes a circular LVOT shape, whereas, in fact,
it is oval in most patients. However, as opposed to what
was previously believed, this underestimation of LVOT
area does not necessarily translate into underestimation
of LV stroke volume and valve EOA. Indeed, TTE over-
estimates the LVOT VTI compared to CMR, which thus
compensates the underestimation of LVOT area and
yields to concordant estimates of valve EOA. With TTE
method, it is assumed that: i) the flow velocity profile in
the LVOT is flat, i.e. mean velocity equals peak velocity,
and ii) the flow velocity profile is homogenous, i.e. mea-
surement of velocity with the pulsed-wave Doppler sam-
ple volume positioned in the center of the LVOT
accurately reflects the average velocity throughout the
whole LVOT cross-section. However, as illustrated in
Figure 4, CMR reveals that flow velocity profile is not
flat and is often skewed with higher velocities along the
anterior and right aspects of the LVOT. Hence, tracing
of the contour of the peak velocity envelopes obtained
by pulsed-wave Doppler at the center of the LVOT
overestimates the actual mean velocity and the VTI in
the LVOT. The overestimation of VTILVOT by TTE
somewhat counterbalances the underestimation of
ALVOT. And consequently, the average stroke volume
and EOA determined by TTE are similar to those deter-
mined by CMR.
Aortic valve EOA
Several previous CMR studies have focused on the mea-
surement of the area of the aortic valve orifice by plani-
metry [5,10-13]. However, it is important to underline
that this “anatomic” orifice area (AOA) is not equivalent
to the EOA. The latter indeed reflects the cross-sec-
tional area of the vena contracta of the transvalvular
flow jet [14,15]. The EOA is generally smaller than the
AVA because there is a contraction of the flow down-
stream of the valve orifice. From a physiological stand-
point, the transvalvular pressure gradient and thus the
LV workload are essentially determined by the EOA and
the magnitude of flow rate. The ratio EOA/AOA, i.e.
the contraction coefficient, may vary from 0.6 to 1.0
depending on the shape of the valve inflow and the geo-
metry of the valve orifice [14,15,27]. Hence, the EOA is
superior to the AOA to accurately quantify the LV
hemodynamic burden associated with the stenosis. Dop-
pler-echocardiography and CMR are the two sole meth-
ods capable of measuring the valve EOA.
Our results are consistent with those of Caruthers et
al., who reported a very good correlation between EOA
determined by CMR with the use of continuity equation
and that obtained by TTE (r = 0.83, SEE = 0.22 cm2)
[6]. In a study where the stroke volume entered in the
continuity equation was estimated by the Simpson
method (i.e. LV end-diastolic volume minus LV end-sys-
tolic volume) instead of stroke volume measured in the
LVOT, Yap et al. obtained an excellent correlation with
TTE (r = 0.91, SEE = 0.17 cm2) [7]. Hagui et al. also
proposed a hybrid method using the stroke volume
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measured by CMR and the aortic jet VTI obtained by
TTE in the continuity equation [9]. This hybrid CMR-
TTE method had a good agreement with the standard
TTE method (bias = -0.01 cm2, limits of agreement:
-0.36 to 0.34). The correlation between CMR- and TTE-
derived EOAs reported in the present study appears to
be better than those reported in previous studies. This
may be due, at least in part, to differences in the popu-
lation samples. Moreover, in the present study, we
tested several locations for the measurement of the aor-
tic jet VTI and found that highest velocities were
obtained at 6 mm downstream to the valve orifice.
These findings suggest that the vena contracta may
actually be closer to the valve orifice compared to what
was assumed (10 mm) in the previous studies [6-10].
In the present study, we also assessed the intra- and
inter- observed variability: first, by repeating the EOA
measurements with the use of the same sets of CMR
and TTE images, and second, by repeating both acquisi-
tion and analysis of images. In both situations, CMR
was found to have much less measurement variability
compared to TTE, which lends further support to the
reliability of this alternative imaging modality to confirm
stenosis severity in the AS population.
Clinical implications
Estimation of EOA by CMR should be contemplated
when Doppler-echocardiographic measurement of EOA
is not feasible or when the findings are discordant: e.g.
valve EOA in the severe range (< 1.0 cm2) but mean
transvalvular gradient in the moderate range (< 40
mmHg) or vice versa [18,19]. Recent studies have
revealed that these discordances are frequent [3,28]. The
first situation (small EOA and low gradient) is often
found in presence of low transvalvular flow. The stroke
volume and thus the transvalvular flow may indeed be
significantly reduced not only in patients with low LV
ejection fraction but also in those with preserved LVEF.
This latter entity was recently described by our group
and was termed: “paradoxical” low flow AS [3,29]. This
entity is characterized by pronounced LV concentric
remodelling, small LV cavity with impaired LV filling
and reduced stroke volume despite preserved LVEF.
These patients with paradoxical low flow AS, who repre-
sent approximately 15-20% of AS population, often exhi-
bit discordance between EOA and gradient and accurate
determination of stroke volume and EOA is crucial in
these patients. CMR may be particularly useful in these
patients to corroborate stenosis severity and guide thera-
peutic management.
Limitations
The main limitations of this study are the relatively
small number of patients with severe AS and the
absence of a gold standard reference method. Unfortu-
nately there is no such method available for in vivo
measurement of valve EOA. The determination of valve
EOA by catheterization with the use of the Gorlin for-
mula also has important limitations and cannot be con-
sidered as a gold standard reference method [30].
Furthermore, this method is associated with increased
risk of cerebral embolism [4].
Conclusions
Underestimation of ALVOT by TTE is compensated by
overestimation of VTILVOT, thereby resulting in a good
concordance between TTE and CMR for estimation of
aortic valve EOA. CMR provides a non-invasive and
reliable alternative to Doppler-echocardiography for the
quantification of AS severity.
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